Stay updated on Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page revision increased from v3.5.3 to v3.5.4, indicating a minor update to the page's revision history. This does not reflect a substantive change to study content or visible functionality.
    Difference
    0.1%
    Check dated 2026-05-16T09:06:04.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page’s footer revision version was updated from v3.5.2 to v3.5.3, indicating an interface/software release rather than a change to the underlying study details.
    Difference
    0.1%
    Check dated 2026-04-24T22:50:45.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T14:16:30.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0, a site version/UI change that does not modify study details.
    Difference
    0.1%
    Check dated 2026-03-19T23:41:51.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; this appears to be a minor metadata update with no visible changes to the study details.
    Difference
    0.1%
    Check dated 2026-03-12T19:36:40.000Z thumbnail image
  9. Check
    107 days ago
    Change Detected
    Summary
    Added Primary peritoneal carcinoma and Fallopian tube cancer to the study's Conditions, and updated the page version from v3.4.1 to v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-12T01:21:50.000Z thumbnail image

Stay in the know with updates to Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial page.